It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Smoking behaviors and alcohol use disorder (AUD), both moderately heritable traits, commonly co-occur in the general population. Single-trait genome-wide association studies (GWAS) have identified multiple loci for smoking and AUD. However, GWASs that have aimed to identify loci contributing to co-occurring smoking and AUD have used small samples and thus have not been highly informative. Applying multi-trait analysis of GWASs (MTAG), we conducted a joint GWAS of smoking and AUD with data from the Million Veteran Program (N = 318,694). By leveraging GWAS summary statistics for AUD, MTAG identified 21 genome-wide significant (GWS) loci associated with smoking initiation and 17 loci associated with smoking cessation compared to 16 and 8 loci, respectively, identified by single-trait GWAS. The novel loci for smoking behaviors identified by MTAG included those previously associated with psychiatric or substance use traits. Colocalization analysis identified 10 loci shared by AUD and smoking status traits, all of which achieved GWS in MTAG, including variants on SIX3, NCAM1, and near DRD2. Functional annotation of the MTAG variants highlighted biologically important regions on ZBTB20, DRD2, PPP6C, and GCKR that contribute to smoking behaviors. In contrast, MTAG of smoking behaviors and alcohol consumption (AC) did not enhance discovery compared with single-trait GWAS for smoking behaviors. We conclude that using MTAG to augment the power of GWAS enables the identification of novel genetic variants for commonly co-occuring phenotypes, providing new insights into their pleiotropic effects on smoking behavior and AUD.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details






1 Yale School of Public Health, New Haven, USA (GRID:grid.47100.32) (ISNI:0000000419368710); VA Connecticut Healthcare System, West Haven, USA (GRID:grid.281208.1) (ISNI:0000 0004 0419 3073)
2 VA Connecticut Healthcare System, West Haven, USA (GRID:grid.281208.1) (ISNI:0000 0004 0419 3073); Yale School of Medicine, New Haven, USA (GRID:grid.47100.32) (ISNI:0000000419368710)
3 University of Pennsylvania Perelman School of Medicine, Philadelphia, USA (GRID:grid.25879.31) (ISNI:0000 0004 1936 8972); Crescenz Veterans Affairs Medical Center, Philadelphia, USA (GRID:grid.410355.6) (ISNI:0000 0004 0420 350X)
4 Yale School of Public Health, New Haven, USA (GRID:grid.47100.32) (ISNI:0000000419368710); Yale School of Medicine, New Haven, USA (GRID:grid.47100.32) (ISNI:0000000419368710)
5 Yale School of Public Health, New Haven, USA (GRID:grid.47100.32) (ISNI:0000000419368710); VA Connecticut Healthcare System, West Haven, USA (GRID:grid.281208.1) (ISNI:0000 0004 0419 3073); Yale School of Medicine, New Haven, USA (GRID:grid.47100.32) (ISNI:0000000419368710)